All Stories

  1. Epilepsy in Asia: Disease burden, management barriers, and challenges
  2. Perampanel, an AMPA receptor antagonist: From clinical research to practice in clinical settings
  3. Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer's disease
  4. Review of clinical studies of perampanel in adolescent patients
  5. Evaluation of safety and efficacy of zonisamide in adult patients with partial, generalized, and combined seizures: an open labeled, noncomparative, observational Indian study
  6. EFFICACY AND TOLERABILITY OF DONEPEZIL 23-MG/DAY VERSUS DONEPEZIL 10-M/DAY IN KOREAN PATIENTS WITH MODERATE TO SEVERE AD: STUDY 326 SUBANALYSIS